Nonthoracotomy versus thoracotomy cardioverter-defibrillator implantation

Long-term outcome

Soo G. Kim, V. Sompalli, John Devens Fisher, Kevin J. Ferrick, Jay N. Gross, R. Brodman, S. Furman

Research output: Contribution to journalArticle

Abstract

We compared the survival of 193 patients treated with implantable cardioverter-defibrillators according to the approach used in implantation: thoracotomy (87 patients) and nonthoracotomy (106 patients). Although the surgical (30-day) mortality rate was higher among thoracotomy patients, we found no difference in long-term survival between the groups. Short-term survival was better in nonthoracotomy patients, but the difference between the groups diminished quickly during the first few months and disappeared by six months. Thus, the results of trials that initially used thoracotomy cardioverter-defibrillators may be largely applicable to patients treated with nonthoracotomy devices.

Original languageEnglish (US)
Pages (from-to)47-50
Number of pages4
JournalCardiology Review
Volume14
Issue number8
StatePublished - 1997

Fingerprint

Defibrillators
Thoracotomy
Survival
Implantable Defibrillators
Equipment and Supplies
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Nonthoracotomy versus thoracotomy cardioverter-defibrillator implantation : Long-term outcome. / Kim, Soo G.; Sompalli, V.; Fisher, John Devens; Ferrick, Kevin J.; Gross, Jay N.; Brodman, R.; Furman, S.

In: Cardiology Review, Vol. 14, No. 8, 1997, p. 47-50.

Research output: Contribution to journalArticle

@article{f8a7724a052545aabb9864f2e5082088,
title = "Nonthoracotomy versus thoracotomy cardioverter-defibrillator implantation: Long-term outcome",
abstract = "We compared the survival of 193 patients treated with implantable cardioverter-defibrillators according to the approach used in implantation: thoracotomy (87 patients) and nonthoracotomy (106 patients). Although the surgical (30-day) mortality rate was higher among thoracotomy patients, we found no difference in long-term survival between the groups. Short-term survival was better in nonthoracotomy patients, but the difference between the groups diminished quickly during the first few months and disappeared by six months. Thus, the results of trials that initially used thoracotomy cardioverter-defibrillators may be largely applicable to patients treated with nonthoracotomy devices.",
author = "Kim, {Soo G.} and V. Sompalli and Fisher, {John Devens} and Ferrick, {Kevin J.} and Gross, {Jay N.} and R. Brodman and S. Furman",
year = "1997",
language = "English (US)",
volume = "14",
pages = "47--50",
journal = "Cardiology Board Review",
issn = "1092-6607",
publisher = "Ascend Media",
number = "8",

}

TY - JOUR

T1 - Nonthoracotomy versus thoracotomy cardioverter-defibrillator implantation

T2 - Long-term outcome

AU - Kim, Soo G.

AU - Sompalli, V.

AU - Fisher, John Devens

AU - Ferrick, Kevin J.

AU - Gross, Jay N.

AU - Brodman, R.

AU - Furman, S.

PY - 1997

Y1 - 1997

N2 - We compared the survival of 193 patients treated with implantable cardioverter-defibrillators according to the approach used in implantation: thoracotomy (87 patients) and nonthoracotomy (106 patients). Although the surgical (30-day) mortality rate was higher among thoracotomy patients, we found no difference in long-term survival between the groups. Short-term survival was better in nonthoracotomy patients, but the difference between the groups diminished quickly during the first few months and disappeared by six months. Thus, the results of trials that initially used thoracotomy cardioverter-defibrillators may be largely applicable to patients treated with nonthoracotomy devices.

AB - We compared the survival of 193 patients treated with implantable cardioverter-defibrillators according to the approach used in implantation: thoracotomy (87 patients) and nonthoracotomy (106 patients). Although the surgical (30-day) mortality rate was higher among thoracotomy patients, we found no difference in long-term survival between the groups. Short-term survival was better in nonthoracotomy patients, but the difference between the groups diminished quickly during the first few months and disappeared by six months. Thus, the results of trials that initially used thoracotomy cardioverter-defibrillators may be largely applicable to patients treated with nonthoracotomy devices.

UR - http://www.scopus.com/inward/record.url?scp=0031462342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031462342&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 47

EP - 50

JO - Cardiology Board Review

JF - Cardiology Board Review

SN - 1092-6607

IS - 8

ER -